Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics: ethical issues and policy options.

Allen Buchanan1, Andrea Califano, Jeffrey Kahn

  • 1Department of Philosophy, University of Arizona, Tucson, AZ, USA.

Kennedy Institute of Ethics Journal
|September 5, 2002
PubMed
Summary

Pharmacogenetics promises safer, more effective drugs through personalized medicine. Addressing ethical concerns like privacy and access is crucial for realizing its full potential in healthcare.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026
Same author

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Nature·2026
Same author

pyVIPER: a fast and scalable Python package for protein activity estimation and master regulator analysis of single-cell RNA sequencing data.

BMC bioinformatics·2026
Same author

Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

JCO precision oncology·2026
Same author

Intermediate Relative Humidity Preserves Respiratory Syncytial Virus via a Semi-Solid Bioaerosol State.

bioRxiv : the preprint server for biology·2026
Same author

A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

The Journal of experimental medicine·2026

Area of Science:

  • Pharmacogenetics
  • Medical Ethics
  • Drug Development

Background:

  • Pharmacogenetics aims to tailor drug therapies for individual patients, enhancing safety and efficacy.
  • Realizing the full benefits of pharmacogenetics requires proactive management of associated ethical challenges.

Purpose of the Study:

  • To identify and analyze the key ethical issues arising from pharmacogenetic research and clinical applications.
  • To propose policy approaches for addressing these identified ethical concerns.

Main Methods:

  • Systematic analysis of ethical issues categorized under six main headings.
  • Review of regulatory oversight, confidentiality, informed consent, drug availability, access, and evolving clinician responsibilities.

Main Results:

Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

Related Experiment Videos

  • Identified six critical ethical domains in pharmacogenetics: regulatory oversight, privacy, consent, drug availability, access, and clinician roles.
  • Developed policy recommendations to navigate these ethical complexities.

Conclusions:

  • Addressing ethical considerations is paramount for the successful integration of pharmacogenetics into clinical practice.
  • Proactive policy development is essential to ensure equitable and responsible use of pharmacogenetic technologies.